Omaveloxolone - Biogen
At a glance
- Drug Originator Dartmouth College; University of Texas M. D. Anderson Cancer Center
- Drug Licenced by Biogen
- Drug Class Analgesics; Anti-inflammatories; Antineoplastics; Eye disorder therapies; Neuroprotectants; Small molecules; Triterpenes
- Mechanism of Action NF-E2-related factor 2 stimulants
- USA Patent Applicants BIOGEN US
- USA Patents 12
- NDAs 1
- International Patents 116
- Patent Applications 52
Disclaimer